US 12226412
Heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators
granted A61KA61K31/4745A61K31/497
Quick answer
US patent 12226412 (Heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators) held by Corcept Therapeutics Incorporated expires Mon Feb 13 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Corcept Therapeutics Incorporated
- Grant date
- Tue Feb 18 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 13 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 8
- CPC classes
- A61K, A61K31/4745, A61K31/497, A61K31/506, A61K31/5377